Is it safe to inject local anaesthetic with adrenaline into the pinna and external nose?
Intended for healthcare professionals
Evidence & Practice Previous     Next

Is it safe to inject local anaesthetic with adrenaline into the pinna and external nose?

Emma Millar Senior house officer, Royal United Hospitals Bath NHS Foundation Trust, Bath, England
Arthur Henderson Registrar, Royal United Hospitals Bath NHS Foundation Trust, Bath, England
Angus Waddell Consultant ear nose and throat surgeon, Great Western Hospitals NHS Foundation Trust, Swindon, England

Adrenaline containing lidocaine preparations such as lignospan are routinely used in ear, nose and throat (ENT) care. Despite this, textbooks and internet resources warn against their use in peripheries, including the nose and ear. As a result, they are commonly avoided by other specialties, such as emergency medicine. This article reports on the findings of a review undertaken to assess the evidence of harm associated with using lignospan in the pinna and external nose. A literature search was carried out, and retrospective data were collected on all elective facial skin lesion surgery in the ENT department at the Great Western Hospital in Swindon between 2005 and 2015. Cases using lignospan in the pinna and nose were included. The literature search revealed no reports of ischaemic complications of the pinna or nose following use of lignospan, or similar preparation. Of the 1,409 cases collected, no ischaemic complications were recorded. The article concludes that adrenaline containing lidocaine preparations such as lignospan are safe for use in the pinna and nose, and should be considered for use in emergency departments.

Emergency Nurse. 25, 09, 31-34. doi: 10.7748/en.2018.e1769

Correspondence

emma.millar4@nhs.net

Peer review

This article has been subject to external double-blind peer review and checked for plagiarism using automated software

Conflict of interest

None declared

Write for us

For information about writing for RCNi journals, contact writeforus@rcni.com

For author guidelines, go to rcni.com/writeforus

Received: 21 August 2017

Accepted: 22 November 2017

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more